Search for: "Mylan, Inc."
Results 341 - 360
of 587
Sorted by Relevance
|
Sort by Date
24 Jan 2011, 8:19 pm
Most lawsuits are brought against those responsible for Reglan believe that manufacturers did not properly label the container side effects.Manufacturers who have filed the appeal are: Actavis, Inc., Mylan, Inc., Teva Pharmaceutical Industries, and UDL Laboratories, Inc. [read post]
5 Aug 2011, 12:29 pm
Manufacturers who have filed the appeal are: Actavis, Inc., Mylan, Inc., Teva Pharmaceutical Industries, and UDL Laboratories, Inc. [read post]
4 Aug 2010, 12:21 am
Mylan Pharmaceuticals Inc. [read post]
30 Apr 2008, 2:18 pm
In more detail, according to this Digitek MedWatch Safety Alert: The products are distributed by Mylan Pharmaceuticals Inc., under a "Bertek" label and by UDL Laboratories, Inc. under a "UDL" label. [read post]
1 Mar 2012, 9:00 pm
Mylan Pharm., Inc., C.A. [read post]
1 Mar 2012, 9:00 pm
Mylan Pharm., Inc., C.A. [read post]
24 Nov 2010, 12:37 am
Use of pipeline system (IP tango) EU: Notes from EU Parliament meeting on innovation+access for medical technologies (KEI) Netherlands: District Court of The Hague declares Dutch part of Bayer’s European patent covering anti-TNF alpha human monoclonal antibodies invalid (Kluwer Patent Blog) Southeast Asia: Generic drug market picks up steam in Southeast Asia, finds Front & Sullivan (GenericsWeb) Spain: Commercial Court No 5 of Barcelona: obtaining price for generic medicament an act of… [read post]
25 Feb 2014, 9:01 am
’”) and Beckman Instruments, Inc. [read post]
25 Oct 2009, 11:07 am
(Perry) with securities law violations for its failure to report timely under Section 13(d) of the Securities Exchange Act of 1934 its beneficial ownership of more than 5 percent of the outstanding common stock of Mylan Laboratories Inc. [read post]
15 Apr 2010, 4:27 am
You can separately subscribe to the IP Think Tank Global Week in Review at the Subscribe page: http://thinkipstrategy.com/subscribe/ Highlights this week included: CAFC denies Vanderbilt’s claim to Cialis patent right: Vanderbilt University v ICOS Corporation (Patently-O) (IPBiz) Paris District Court: Basic patent for Losartan covers any product comprising Losartan: Du Pont v Mylan Losartan SPC case (EPLAW) General WHO documents from counterfeit meeting now online (IP… [read post]
3 Nov 2010, 1:21 am
No – discussion of patent-eligibility standards for genes (Patent Baristas) US: Appellees file reply brief in Therasense v Becton Dickinson (Patent Docs) US: Another Capitol Hill missive objects to the inclusion of patent settlement provisions in FY 2011 Appropriations Bill (FDA Law Blog) US: REMS and 180-day exclusivity forfeiture – some interesting disclosures to the SEC (FDA Law Blog) Products Botox (Botulinum) – EU: General Court upholds opposition to BOTUMAX Community… [read post]
22 Dec 2010, 3:01 am
Mylan Inc. et al. [read post]
18 Feb 2010, 10:34 am
Most notably there’s Mylan Laboratories, Inc. v. [read post]
13 Sep 2019, 11:09 am
Mylan Pharmaceuticals Inc., 896 F.3d 1332 (Fed. [read post]
12 Jul 2010, 9:40 am
Mylan Pharmaceuticals Inc., C.A. 09-184-... [read post]
23 Jan 2019, 10:08 am
Mylan Pharmaceuticals, Inc., et al. [read post]
2 Oct 2012, 12:49 pm
He’s also used his stakes to influence the direction of such companies as XO Communications, Mylan Laboratories, Time Warner Inc. and Mentor Graphics, among others. [read post]
16 May 2012, 12:22 pm
Mylan Pharmaceuticals, Inc., ___ F. [read post]
11 Nov 2017, 11:00 am
Mylan Institutional LLC, 846 F.3d1213, 1221–23 (Fed. [read post]
18 Mar 2010, 2:30 am
Mylan Pharmaceuticals, Inc. et al. [read post]
